Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.
Wensing
Annemarie Mj
AM
Boucher
Charles Ab
CA
van Kasteren
Marjo
M
van Dijken
Pieter J
PJ
Geelen
Sybil P
SP
Juttmann
Job R
JR
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D024921:Drug Resistance, Multiple, Viral; D000077560:Enfuvirtide; D005260:Female; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use*; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D010446:Peptide Fragments / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D013449:Sulfonamides
D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D000077560:Enfuvirtide; C107201:tipranavir